Amifampridine Phosphate
SMA-001
Phase 2 small_molecule completed
Quick answer
Amifampridine Phosphate for Muscular Atrophy, Spinal is a Phase 2 program (small_molecule) at CATALYST PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CATALYST PHARMACEUTICALS, INC.
- Indication
- Muscular Atrophy, Spinal
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed